GLPG0259: Phase I data

A double-blind, placebo-controlled, multiple ascending-dose, Belgian Phase I trial in 24 healthy volunteers showed that 25, 50 and 75 mg oral GLPG0259 plus methotrexate for 14 days were safe and had a...